Neutrophil elastase (NE) degrades basal lamina and extracellular matrix molecules, and recruits leukocytes during inflammation; however, a basic understanding of the role of NE in stroke pathology is lacking. We measured an increased number of extravascular NE-positive cells, as well as increased levels of tissue elastase protein and activity, following transient middle cerebral artery occlusion (tMCAo). Both pharmacologic inhibition of NE with ZN200355 (ZN), and genetic deletion of NE, significantly reduced infarct volume, blood-brain barrier disruption, vasogenic edema, and leukocyte-endothelial adherence 24 h after tMCAo. ZN also reduced infarct volume in MMP9-null mice following tMCAo. There were, however, no reductions in infarct volume or vasogenic edema in NE-null mice in two models of permanent middle cerebral artery occlusion. Our findings confirm the involvement of NE in neurovascular stroke pathology, when reperfusion allows neutrophils access to vulnerable brain, with pharmacologic or genetic inhibition of NE being both neuro-and vasculo-protective in this setting.
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Leukocytes play a critical role in post-ischemic inflammation and secondary neurovascular injury in most tissues, including brain (for review, see: Man et al., 2007; Wang et al., 2007) . Mechanistically, this results from oxidative injury secondary to the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-associated respiratory burst and/or proteolytic injury from the release of destructive enzymes. Both of these events can occur independent of leukocyte transmigration across endothelium into parenchyma (Shapiro 2002) . With respect to the protease pathway, the 33-kDa serine proteinase elastase (E.C. 3.4.21.37) is stored in a biologically active form within primary neutrophil granules. Neutrophil elastase (NE) is important in host defense (Belaaouaj et al., 1998) , and degranulation stimuli during inflammation can include the paracrine action of platelet activating factor and interleukin-8 released from endothelial cells (Henriksen and Sallenave, 2008) . NE degrades structural matrix proteins (e.g. elastin, collagens, laminins, and fibronectin), resulting in increased vascular permeability and hemorrhage in non-cerebral tissues (Ishikawa et al., 2003; Houtz et al., 2004) .
In conjunction with membrane degradation, NE also regulates leukocyte adhesion and diapedesis/transmigration in peripheral vascular beds in response to pro-inflammatory stimuli (Woodman et al., 1993; Young et al., 2004) . NE-mediated degradation of endothelial junction proteins, in addition to the aforementioned proteolysis of matrix proteins, "clears a path" for the transmigrating leukocytes during diapedesis (Hermant et al., 2003; Ionescu et al., 2003) . In brain, exogenous delivery of NE, following either intracarotid infusion (Nagy et al., 1998) or intracerebral injection (Armao et al., 1997) , increases blood-brain barrier (BBB) permeability, suggesting that BBB tight junctions, basal lamina, and perhaps even cortical endothelial cells are vulnerable to NE-mediated proteolysis during pathological conditions associated with cortical inflammation.
Studies of non-CNS tissues using pharmacologic inhibitors of NE highlight the specific role played by NE in ischemia-reperfusion pathology. NE inhibition reduces leukocyte adherence and extravasation in intestinal and myocardial ischemia (Zimmerman and Granger, 1990; Tiefenbacher et al., 1997) . Post-ischemic vasogenic edema in the rabbit lung (Kishima et al., 1998) , as well as in rat hindlimb (Welbourn et al., 1991) and liver (Okajima et al., 2004) , can be attenuated by NE inhibitors. Few studies, however, have investigated endogenous NE in stroke, despite evidence of significant neutrophil accumulation following cerebral ischemia (Wang et al., 2007; Gelderblom et al., 2009) . One study by Shimakura et al. (2000) showed that the continuous infusion of an NE inhibitor, ONO-5046, reduced postischemic vasogenic edema and infarct volume 24 h following permanent middle cerebral artery occlusion in rats. ONO-5046 has also been shown to protect hippocampal neurons following forebrain ischemia (Matayoshi et al., 2009) . While these findings are consistent with NE mediating post-ischemic neurovascular dysfunction, more Neurobiology of Disease 35 (2009) 82-90 
